A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
IPH6501, a CD20-targeted NK cell engager armed with non-alpha IL-2, shows preclinical efficacy and tolerability in B-NHL.
Related Articles
Meet Evo, the DNA-trained AI that creates genomes from scratch
ChatGPT-like model learns on its own to devise new proteins and genetic sequences
The first people on Tasmania brought fire and forever changed the land
Study of charcoal and pollen could give Aboriginal advocates of traditional burns “more voice at the table”
A breakthrough cancer immunotherapy is now taking aim at autoimmune disease
CAR-T therapy is generating excitement for lupus, scleroderma, and other conditions as clinical trials expand
Micronuclear collapse from oxidative damage
Chromosome-containing micronuclei are a hallmark of aggressive cancers. Micronuclei frequently undergo irreversible collapse, exposing their enclosed chromatin to the cytosol. Micronuclear rupture catalyzes chromosomal rearrangements,…
Navigating the mutation maze: An oncogenic driver’s guide to macrophage reprogramming
The mechanisms by which oncogenic mutations and anatomical locations work together to influence the immune environment within tumors are not well understood. In this issue…
With winged legs, orchid mantis sets gliding record
Camouflaged like a flower, these predators also have a getaway trick
Gatekeepers of the brain: Identifying hidden mechanisms of type A GABA receptor signaling and assembly
Identifying hidden mechanisms of type A GABA receptor signaling and assembly
Prospect of RFK Jr. as head of HHS panics many in medical science community
Robert F. Kennedy Jr. has vowed radical change including scrutinizing long-standing vaccines and slashing staff at research and regulatory agencies
Prospect of RFK Jr. as head of HHS panics many in medical science community
Robert F. Kennedy Jr. has vowed radical change including scrutinizing long-standing vaccines and slashing staff at research and regulatory agencies
Gatekeepers of the brain: Identifying hidden mechanisms of type A GABA receptor signaling and assembly
Identifying hidden mechanisms of type A GABA receptor signaling and assembly